I now have all the key content from Schwartz's on pneumonia. Let me compile the comprehensive answer.
Pneumonia - Schwartz's Principles of Surgery (11th Ed.)
Schwartz's covers pneumonia primarily from a surgical perspective, addressing it in the contexts of postoperative complications, ventilator-associated infection, lung abscess, aspiration, and bronchiectasis.
1. Postoperative Pneumonia & Predisposing Factors
Pulmonary atelectasis is a key precursor - it reduces functional residual capacity (FRC) and predisposes to pneumonia. Contributing factors include:
- Poor pain control → inadequate inspiratory effort → lower lobe collapse
- Inadequate pulmonary toilet → bronchial plugging, lobar collapse
- Aspiration (from anesthesia, stroke, drugs/alcohol, esophageal disease)
Prevention of atelectasis/pneumonia:
- Sit patient >45° (increases FRC by ≥700 mL)
- Early ambulation
- Adequate pain control - epidural analgesia significantly lowers pneumonia risk vs. patient-controlled analgesia
- Head of bed at 30-45° for ventilated patients
- Adequate tidal volumes (8-10 mL/kg) in ventilated patients
2. Ventilator-Associated Pneumonia (VAP)
Pneumonia is the second most common nosocomial infection overall and the most common infection in ventilated patients.
- VAP occurs in 15% to 40% of ventilated ICU patients
- Probability rate: 5% per day, up to 70% at 30 days
- 30-day mortality of nosocomial pneumonia: up to 40% (depends on organism and timeliness of antibiotics)
Diagnosis requires:
- Abnormal chest X-ray
- Fever
- Productive cough with purulent sputum
- No other obvious fever source
The presence of two clinical findings + CXR changes significantly increases diagnostic likelihood. Bronchoalveolar lavage (BAL) for Gram stain and culture is recommended; quantitative cultures (threshold: ≥100,000 CFU) help confirm diagnosis.
Organisms:
- Nosocomial pneumonia: 60-70% gram-negative bacteria
- Pseudomonas and Acinetobacter spp. are particularly virulent - double antibiotic coverage may be appropriate if local prevalence is high
- Immunosuppressed patients: also susceptible to Salmonella, Legionella, Pneumocystis carinii (jirovecii), atypical mycobacteria, fungi
Treatment:
- Begin broad-spectrum antibiotics immediately once pneumonia suspected
- Narrow spectrum once culture sensitivities are known
- Track the institution's antibiogram every 6-12 months - one of the most helpful tools in managing pneumonia
Prevention of VAP: Wean from mechanical ventilation as soon as oxygenation and inspiratory effort allow. Protocol-driven approaches are recognized as beneficial.
3. Aspiration Pneumonitis vs. Aspiration Pneumonia
| Feature | Pneumonitis | Pneumonia |
|---|
| Cause | Chemical injury from aspirated gastric acid | Bacterial infection from aspirated material |
| Antibiotics | Not indicated | Required (broad-spectrum initially) |
| Treatment | Supportive care, oxygenation (similar to ARDS management); early aggressive bronchoscopy for suctioning | Antibiotics guided by culture |
| Mortality | Up to 70-80% in hospitalized patients | Depends on organism and timeliness |
Forced diuresis for anasarca/over-resuscitation remains controversial - complications include electrolyte disturbances, metabolic alkalosis, hypotension, and acute kidney injury.
4. Lung Abscess (Necrotizing Pneumonia)
Etiology Classification
Primary (lung as source):
- Necrotizing pneumonia - caused by S. aureus, Klebsiella, Pseudomonas, Mycobacterium, Bacteroides, Fusobacterium, Actinomyces, Entamoeba, Echinococcus
- Aspiration pneumonia - anesthesia, stroke, drugs/alcohol
- Esophageal disease - achalasia, Zenker's diverticulum, GERD
- Immunodeficiency - cancer, chemotherapy, diabetes, organ transplantation, steroid therapy, malnutrition
Secondary (lung involved from elsewhere):
- Bronchial obstruction (neoplasm, foreign body)
- Systemic sepsis (septic pulmonary emboli, seeding of pulmonary infarct)
- Pulmonary trauma (infected hematoma/contusion, contaminated foreign body)
- Direct extension from extraparenchymal infection (pleural empyema, mediastinal/hepatic/subphrenic abscess)
Microbiology
Post-aspiration lung abscesses are typically polymicrobial (average 2-4 isolates):
- ≥50% purely anaerobic bacteria
- 25% mixed aerobes + anaerobes
- ≤25% aerobes only
Clinical Features
- Productive cough, fever (>38.9°C), chills, leukocytosis (>15,000 cells/mm³)
- Weight loss, fatigue, malaise, pleuritic chest pain, dyspnea
- More indolent course possible: weeks-months of low-grade fever, night sweats, anemia
- After aspiration: cavitation in 1-2 weeks; 40-75% produce putrid/foul-smelling sputum
- Severe complications (massive hemoptysis, pyopneumothorax, septic shock) are rare in the antibiotic era
- Mortality: 5-10% overall; 9-28% in immunosuppressed patients
Diagnosis
- CXR is primary tool - shows density/mass with thin-walled cavity; air-fluid level indicates communication with tracheobronchial tree
- CT chest when CXR is equivocal - clarifies diagnosis, identifies endobronchial obstruction
- Differential: cavitating lung carcinoma, loculated empyema, infected lung cysts/bullae, TB, bronchiectasis, fungal infections, Wegener's granulomatosis
- Bronchoscopy for culture (ideally before antibiotics)
Treatment
Medical treatment is primary - spontaneous drainage via the tracheobronchial tree is usual.
Surgical indications (Table 19-18):
- Failure of medical therapy
- Abscess under tension
- Abscess increasing in size during appropriate treatment
- Contralateral lung contamination
- Abscess >4-6 cm in diameter
- Necrotizing infection with multiple abscesses, hemoptysis, abscess rupture, or pyopneumothorax
- Inability to exclude cavitating carcinoma
Drainage options:
- Tube thoracostomy
- Percutaneous (radiographically guided) drainage
- Surgical cavernostomy
- Surgical resection required in <10% of patients
- Lobectomy is preferred for bleeding or pyopneumothorax
- Intraoperative: protect contralateral lung with double-lumen tube, bronchial blocker, or contralateral mainstem intubation
- Surgical treatment: 90% success rate, mortality 1-13%
5. Pneumonia as a Cause of Bronchiectasis
Diffuse pneumonic processes - including necrotizing bacterial pneumonia, pertussis/measles pneumonia, severe influenza, and varicella pneumonia - can lead to widespread bronchiectasis (permanent dilation of bronchi with wall thickening). This is a key acquired cause of bronchiectasis, particularly in post-infectious settings.
6. Inhalation Injury & Pneumonia (Burn Patients)
- Ventilator-associated pneumonia is especially common in patients with inhalation injury
- BAL within 24 hours of inhalation injury has a high rate of positive cultures, helping isolate organisms early
- "Pneumonia" nomenclature is complicated in this population by the background of inhalation injury
Sources: SCHWARTZ'S PRINCIPLES OF SURGERY, 11th Edition - Chapters on Surgical Complications (Ch. 12), Critical Care (Ch. 13), Chest Wall, Lung, Mediastinum & Pleura (Ch. 19), and Burns (Ch. 8)